- Market Capitalization, $K 61,064
- Shares Outstanding, K 6,916
- Annual Sales, $ 50,820 K
- Annual Income, $ -5,340 K
- 60-Month Beta 1.82
- Price/Sales 1.19
- Price/Cash Flow N/A
- Price/Book N/A
|Period||Period Low||Period High||Performance|
| || |
-0.43 (-4.77%)since 07/02/21
| || |
-1.12 (-11.53%)since 05/05/21
| || |
+1.61 (+23.07%)since 08/05/20
The is expected to exceed more than US$ 500 Billion by 2024 at a CAGR of 6% in the given forecast period.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report Allergan Plc, Valeant...
Selbyville, Delaware. The report on Ocular Drug Delivery Mode market is a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections...
The new release by Eon Market Research with the title , Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast 2021 to 2027 is intended to give insights into the current trends and...
Factors contributing to high CAGR are growing prevalence of diabetes along with rising incidence of blindness. Moreover, increase in purchasing power and the dread of losing vision have augmented the expenditure...
The Global is estimated to value over USD 19 billion by 2027 end at a CAGR of over 6.8% during the forecast period 2020 to 2027.
The Summer Solstice - Best Ideas from the Buy-Side will take place on June 1-4, 2021, where 35 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor...
Alimera Sciences, Inc. (Nasdaq: ALIM) ("Alimera"), a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals, today announced that management...
Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a leader in the commercialization and development of prescription ophthalmic pharmaceuticals, has announced the expansion of its leadership team with the...
NEW YORK, NY / ACCESSWIRE / April 29, 2021 / Alimera Sciences, Inc. (NASDAQ:ALIM) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on April 29, 2021 at 9:00...